This suggests that the ACE2-QMP fusion design can provide its mode of action both locally and systemically, making it highly relevant in the context of respiratory infectious diseases like COVID-19, where the lungs serve as the primary site of SARS-CoV-2 infection (2). This evidence concerns the gene ACE2 and COVID-19.